ACT-HIB Haemophilus type b conjugate vaccine powder for injection with needle free diluent syringe Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

act-hib haemophilus type b conjugate vaccine powder for injection with needle free diluent syringe

sanofi-aventis australia pty ltd - haemophilus type b polysaccharide, quantity: 10 microgram; tetanus protein, quantity: 18 microgram - injection, powder for - excipient ingredients: trometamol; sucrose - for use in infants from 2 months to 5 years of age for active immunization against invasive disease caused by the haemophilus influenzae type b.